John Ripplinger - Imaflex Vice President - Corporate Affairs
IFX Stock | CAD 1.43 0.02 1.38% |
President
Mr. John Ripplinger has appointed as Vice President Corporationrationrate Affairs of the Company, effective Sept. 6, 2016. Prior to joining Imaflex, Mr. Ripplinger worked with BCE, Bell Canada, Bell Nordiq Group, Miranda Technologies and Neptune Technologies since 2016.
Tenure | 8 years |
Professional Marks | MBA |
Address | 5710 Notre Dame Street West, Montreal, QC, Canada, H4C 1V2 |
Phone | 514 935 5710 |
Web | https://www.imaflex.com |
Imaflex Management Efficiency
The company has return on total asset (ROA) of 0.051 % which means that it generated a profit of $0.051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0749 %, meaning that it generated $0.0749 on every $100 dollars invested by stockholders. Imaflex's management efficiency ratios could be used to measure how well Imaflex manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.01 in 2024. Return On Capital Employed is likely to drop to 0.04 in 2024. At this time, Imaflex's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 57.8 M in 2024, whereas Net Tangible Assets are likely to drop slightly above 30.7 M in 2024.Similar Executives
Showing other executives | PRESIDENT Age | ||
Pascal Hurtubise | Boralex | N/A | |
Richard Wallace | Saputo Inc | N/A | |
Kevin Pankratz | Canfor | N/A | |
Paul Corney | Saputo Inc | N/A | |
James Kenner | Stella Jones | N/A | |
Marla Eichenbaum | Stella Jones | N/A | |
Tom Atherton | Saputo Inc | N/A | |
Nicolas Wolff | Boralex | N/A | |
Mark Feldinger | Canfor | N/A | |
Bob Hayes | Canfor | N/A | |
Stephen Mackie | Canfor | N/A | |
Silvana Travaglini | Stella Jones | 52 | |
David Whitted | Stella Jones | N/A | |
Alan Nicholl | Canfor | N/A | |
Patrick Elliott | Canfor | N/A | |
Carl Colizza | Saputo Inc | N/A | |
Kevin Comerford | Stella Jones | N/A | |
Terry Brockman | Saputo Inc | N/A | |
Leanne Cutts | Saputo Inc | N/A | |
Gordon Murray | Stella Jones | N/A | |
W Downey | Stella Jones | N/A |
Management Performance
Return On Equity | 0.0749 | ||||
Return On Asset | 0.051 |
Imaflex Leadership Team
Elected by the shareholders, the Imaflex's board of directors comprises two types of representatives: Imaflex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Imaflex. The board's role is to monitor Imaflex's management team and ensure that shareholders' interests are well served. Imaflex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Imaflex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Joseph Abbandonato, Chairman, CEO and Pres | ||
Robert Therrien, Director Finance | ||
Stephan Yazedjian, President CEO | ||
John Ripplinger, Vice President - Corporate Affairs | ||
Tony Abbandonato, Secretary Manufacturing | ||
Ralf Dujardin, VP of Marketing and Innovation |
Imaflex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Imaflex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0749 | ||||
Return On Asset | 0.051 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.14 % | ||||
Current Valuation | 86.36 M | ||||
Shares Outstanding | 52.09 M | ||||
Shares Owned By Insiders | 44.78 % | ||||
Shares Owned By Institutions | 10.16 % | ||||
Number Of Shares Shorted | 4.37 K | ||||
Price To Earning | 11.04 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Imaflex Stock Analysis
When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.